A significant change in Norwegian gynecologist's attitude to hormone therapy is observed after the results of the Women's Health Initiative Study

Acta Obstetricia et Gynecologica Scandinavica

Volumn 84, Issue 1, 2005, Pages 92-93

  Moen, Mette Haase ^a   Nilsen, Stein Tore ^b   Iversen, Ole Erik ^c  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b Rogaland Hospital   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Attitudes; Hormone therapy

Indexed keywords

ARTICLE; CLINICAL PRACTICE; FEMALE; GYNECOLOGY; HEALTH PROGRAM; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; NORWAY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL;

ATTITUDE OF HEALTH PERSONNEL; FEMALE; GYNECOLOGY; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; NORWAY; PHYSICIANS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 13144256709     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2005.00628.x     Document Type: Article

References (6)

1. Nilsen ST, Fredriksen T, Iversen OE, Moen MH. Norske gynekologers holdninger til og praksis ved hormonsubstitusjonsbehandling i klimakteriet. [Attitude to and practice of Norwegian gynecologists concerning hormone replacement therapy in climacteric.] (In Norwegian with English Abstract.) Tidsskr Nor Lægeforen 1998; 118: 2940-3.
2. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
3. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M et al. HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002; 288: 49-57.
4. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS). JAMA 1998; 280: 605-13.
5. Moen MH, Fredriksen T, Nilsen ST, Iversen OE. Bruk av hormonsubstitusjon blant norske kvinnelige gynekologer og mannlige gynekologers partnere. [Use of hormone replacement therapy among female gynecologists and partners of male gynecologists in Norway.] (In Norwegian with English Abstract.) Tidsskr Nor Lægeforen 1998; 118: 2944-6.
6. Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 2004; 140: 184-8.